Solabegron zwitterion and uses thereof
US10065922B2 · kind B2 · utility
6Cited by
22References
126Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2016 |
| Grant date | Sep 4, 2018 |
| Priority date | — |
| Expiry date | Feb 23, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.